Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
March 04 2019 - 4:30PM
Edgar (US Regulatory)
Filed by Edge Therapeutics, Inc.
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed under Rule 14a-6(b) of the Securities Exchange Act of 1934
Subject Company: Edge Therapeutics, Inc.
Commission File No. 001-37568
EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Historical Stock Chart
From May 2024 to Jun 2024
EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Edge Therapeutics, Inc. (NASDAQ): 0 recent articles
More Edge Therapeutics, Inc. News Articles